StonvexLoading…
StonvexStonvexStonvexCore line items from PAMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $141.88M | $598.06M | $456.74M | $306.48M |
Operating Income | $-271.00K | $-64.06M | $-25.97M | $-20.26M |
Net Income | $-8.00K | $-52.61M | $-23.36M | $-9.63M |
EPS (Diluted) | $0.00 | $-2.48 | $-1.10 | $-0.83 |
Total Assets | $681.02M | $697.91M | $715.25M | $707.87M |
Total Liabilities | $470.60M | $487.43M | $475.74M | $462.95M |
Cash & Equivalents | $40.52M | $35.23M | $68.76M | $68.92M |
Free Cash Flow OCF − CapEx | $-17.09M | $-23.41M | $1.57M | $-943.00K |
Shares Outstanding | 20.94M | 20.93M | 20.93M | 20.93M |